Metric Properties of de Morton Mobility Index

Musculoskeletal Diseases Clinical Trial

— DEMMIURIS  

Official title:

Metric Properties of de Morton Mobility Index in Rehabilitation Patients With Musculoskeletal Impairments

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04762927
• Other study ID #: URIS202101
• Status: Completed
• Start date: January 1, 2021
• Est. completion date: December 31, 2021

Study information

• Verified date: March 2022
• Source: University Rehabilitation Institute, Republic of Slovenia
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Metric properties (convergent validity, predict validity, known-groups validity, responsiveness, floor and ceiling effects, minimal clinically important difference) of the de Morton Mobility Index (DEMMI) in patients with musculoskeletal impairments undergoing impatient rehabilitation will be investigated.

Description:

Convergent validity of DEMMI will be assessed in terms of correlations with the other outcome measures. Known-groups validity will be demonstrated by differences in DEMMI scores between patients who were not able to walk and those who were able to walk with or without walking aid. Predictive validity of DEMMI at admission for functional independence at discharge from rehabilitation will be estimated. The minimal clinically important difference of DEMMI, responsiveness and floor or ceiling effects will also be estimated.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: December 31, 2021
• Est. primary completion date: December 31, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• admission to inpatient rehabilitation
• written informed consent

Exclusion Criteria:

• associated impairments of the central nervous system or other severe health conditions

Related Conditions & MeSH terms

• Musculoskeletal Diseases

Locations

Country	Name	City	State
Slovenia	University Rehabilitation Institute, Republic of Slovenia	Ljubljana

Sponsors (1)

Lead Sponsor	Collaborator
University Rehabilitation Institute, Republic of Slovenia

Country where clinical trial is conducted

Slovenia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	de Morton Mobility Index - change	DEMMI is a unidimensional 15-item measure of mobility for adults	Approximately 30 days (difference between admission and discharge)
Secondary	Ten-meter Walk Test	10mWT assesses comfortable walking speed over the distance of 10 meters	Approximately 30 days (difference between admission and discharge)
Secondary	Six-minute Walk Test - change	6mWT assesses assess aerobic capacity and endurance	Approximately 30 days (difference between admission and discharge)
Secondary	Functional Independence Measure - change	FIM is an 18-item two-dimensional instrument that explores physical and psychosocial functioning	Approximately 30 days (difference between admission and discharge)
Secondary	EQ-5D-3L - change	EQ-5D-3L is a patient-reported instrument for measuring HRQOL	Approximately 30 days (difference between admission and discharge)